Press coverage about Danaher (NYSE:DHR) has trended somewhat positive on Sunday, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Danaher earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned news headlines about the conglomerate an impact score of 45.977686094247 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
These are some of the headlines that may have impacted Accern Sentiment Analysis’s analysis:
- Financial Counselors Inc. Cuts Holdings in Danaher Co. (DHR) (americanbankingnews.com)
- Eagle Asset Management Inc. Decreases Stake in Danaher Co. (DHR) (americanbankingnews.com)
- Danaher Co. (DHR) Holdings Reduced by State of Tennessee Treasury Department (americanbankingnews.com)
- Top Analyst Reports for Bristol-Myers, Honda & Danaher (finance.yahoo.com)
- Raymond James Financial Services Advisors Inc. Acquires 2,720 Shares of Danaher Co. (DHR) (americanbankingnews.com)
DHR has been the topic of several analyst reports. Citigroup boosted their price objective on shares of Danaher to $107.00 and gave the stock a “buy” rating in a research note on Friday, December 15th. Robert W. Baird reissued a “buy” rating on shares of Danaher in a research note on Friday, January 12th. Barclays initiated coverage on shares of Danaher in a research note on Thursday, February 15th. They issued an “overweight” rating and a $110.00 price objective on the stock. Royal Bank of Canada reissued a “hold” rating and issued a $96.00 price objective on shares of Danaher in a research note on Thursday, January 4th. Finally, Stifel Nicolaus boosted their price objective on shares of Danaher from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Wednesday, January 31st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. Danaher currently has an average rating of “Buy” and a consensus price target of $100.68.
Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.03. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The business had revenue of $5.09 billion for the quarter, compared to analyst estimates of $4.97 billion. During the same quarter in the previous year, the business earned $1.05 earnings per share. Danaher’s revenue for the quarter was up 10.9% on a year-over-year basis. equities analysts anticipate that Danaher will post 4.37 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Thursday, March 29th will be issued a dividend of $0.16 per share. The ex-dividend date is Wednesday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 0.64%. This is a positive change from Danaher’s previous quarterly dividend of $0.14. Danaher’s dividend payout ratio is currently 16.00%.
In other news, CFO Daniel L. Comas sold 62,989 shares of the company’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $101.96, for a total transaction of $6,422,358.44. Following the transaction, the chief financial officer now owns 227,805 shares in the company, valued at $23,226,997.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Angela S. Lalor sold 42,988 shares of the company’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the transaction, the senior vice president now owns 82,008 shares in the company, valued at approximately $8,388,598.32. The disclosure for this sale can be found here. Insiders have sold 288,123 shares of company stock worth $29,162,927 in the last quarter. Company insiders own 12.20% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This report was originally published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this report can be accessed at https://www.tickerreport.com/banking-finance/3222047/danaher-dhr-receives-daily-news-impact-rating-of-0-15.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.